Ma Li

2024,; 2006,.: 2006.07-2011.06,,,,2011.07-,,,,2017.12,.:,, 82273052,Piwil2 PDK1,2023-01-01 2026-12-31,52:: 1. LiMA,JuanMA,XinSUN,HonggangLIU.Bispecifcanti-CD3xanti-CD155antibodymediatesT-cellimmunotherapyinhumanhaematologicmalignancies. I nvestigationalNewDrugs,2023,41(3):522-531. 2.,..,2021,35(6):350-352. 3.,,,,,,,,,,,. 10.,2021,37(12):1251-1254. 4.,,,,,,,,,. 10., 2021,37(7):771-775. 5.,,,,,,,,.., 2 021,35(2): 73~76,80. 6. LiMA,XiaoCONG,MaiSHI,Xiu-hongWANG,Hai-yanLIUandMei-luBIAN.Distributionofhumanpapillomavirusgenotypesincervicallesions. ExperimentalandTherapeuticMedicine, 2017,13(2):535-541.,,: 1. 、...,:2013,12. 2.,...,:2009.5. 3.,...,:2008.9. 4.,...,:2008.6. 5.L.MaximilianBuja//GerhardR.F.Krueger,...,:2008.5.: 2022 10; 5.: 2007 ~2009 “ ”;2009 25;2015 “ ”;.